{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:14:58Z","timestamp":1788243298667,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent negative symptoms and cognitive deficits remain major obstacles to functional recovery in schizophrenia. These impairments are often only partially responsive to antipsychotic treatment and may persist even when other symptoms are clinically stable. Psychosocial interventions show inconsistent efficacy, and commonly used non-invasive brain stimulation techniques have limited ability to target deeper cortical regions. Transcranial temporal interference stimulation (tTIS) has recently emerged as a promising approach for modulating neural activity in such regions. This trial aims to evaluate the clinical efficacy of tTIS targeting the dorsal anterior cingulate cortex (dACC) in individuals with schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-four participants with schizophrenia will be enrolled in a parallel-group, sham-controlled trial. After random allocation, half of the participants will receive active stimulation and the remainder will receive sham stimulation. Group assignment will be blinded from participants and clinical evaluators. Each participant will complete 10 sessions over 2 weeks, with one 30-minute session scheduled on each weekday. Assessments will be completed before the first session, after the treatment course, and 4 weeks after treatment completion. Evaluation will include symptom ratings, neuropsychological testing, behavioral tasks, and multimodal neuroimaging. The primary endpoint is the baseline-adjusted between-group difference in the Positive and Negative Syndrome Scale negative symptom subscale (PANSS-NS) score at T1. The PANSS-NS score at T2 will be analyzed as a secondary outcome to evaluate the durability of the treatment effect. The Brief Assessment of Cognition in Schizophrenia composite z-score and the Scale for the Assessment of Negative Symptoms total score are prespecified as key secondary outcomes. Participants will be included in the primary analysis according to their original treatment assignment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study aims to determine whether dACC-targeted tTIS is feasible and clinically promising in schizophrenia. By combining symptom evaluation with cognitive, behavioral, and imaging measures, the trial may also generate preliminary evidence about treatment-related neural changes. The results will help guide the design of future studies evaluating deep-targeted non-invasive stimulation in psychiatric populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:related-object>\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/<\/jats:ext-link>\n                      , identifier NCT07658898.\n                    <\/jats:related-object>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1915709","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:34:08Z","timestamp":1788240848000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dorsal anterior cingulate cortex-targeted transcranial temporal interference stimulation for negative symptoms and cognitive impairment in schizophrenia: a participant- and assessor-blinded, sham-controlled randomized controlled trial protocol"],"prefix":"10.3389","volume":"17","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manling","family":"Long","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]},{"name":"School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]},{"name":"School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Ma","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengfen","family":"Gong","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia-an overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mcna.2022.05.005","article-title":"Schizophrenia: One name, many different manifestations","volume":"107","author":"Faden","year":"2023","journal-title":"Med Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.08.005","article-title":"Long-term trajectories of cognitive deficits in schizophrenia: A critical overview","volume":"30","author":"Shmukler","year":"2015","journal-title":"Eur Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30050-6","article-title":"Negative symptoms of schizophrenia: New developments and unanswered research questions","volume":"5","author":"Galderisi","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.05.024","article-title":"Noninvasive deep brain stimulation via temporally interfering electric fields","volume":"169","author":"Grossman","year":"2017","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1092539","article-title":"A novel non-invasive brain stimulation technique: \u201ctemporally interfering electrical stimulation","volume":"17","author":"Guo","year":"2023","journal-title":"Front Neurosci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.633988","article-title":"Orientation of temporal interference for non-invasive deep brain stimulation in epilepsy","volume":"15","author":"Missey","year":"2021","journal-title":"Front Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41593-023-01456-8","article-title":"Non-invasive temporal interference electrical stimulation of the human hippocampus","volume":"26","author":"Violante","year":"2023","journal-title":"Nat Neurosci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.70160","article-title":"Temporal interference stimulation boosts working memory performance in the frontoparietal network","volume":"46","author":"Zheng","year":"2025","journal-title":"Hum Brain Mapp"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29967","article-title":"Transcranial temporal interference stimulation of the right globus pallidus in parkinson\u2019s disease","volume":"40","author":"Yang","year":"2025","journal-title":"Mov Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.31.25324806","article-title":"Efficacy and safety of transcranial temporal interference stimulation for improving negative symptoms and cognition in schizophrenia: A pilot study","author":"Wang","year":"2025","journal-title":"medRxiv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1186\/s12888-025-07158-8","article-title":"Individualized transcranial temporal interference stimulation (tTIS) for cognitive impairments and negative symptoms in patients with schizophrenia: A study protocol for a randomized controlled trial","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-070815-013952","article-title":"Dorsal anterior cingulate cortex: A bottom-up view","volume":"39","author":"Heilbronner","year":"2016","journal-title":"Annu Rev Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.07.007","article-title":"The expected value of control: An integrative theory of anterior cingulate cortex function","volume":"79","author":"Shenhav","year":"2013","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbac177","article-title":"Controllability of functional brain networks and its clinical significance in first-episode schizophrenia","volume":"49","author":"Li","year":"2022","journal-title":"Schizophr Bull"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00901-5","article-title":"A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia","volume":"26","author":"Coughlin","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2020.01.021","article-title":"Glutamate and dysconnection in the salience network: Neurochemical, effective connectivity, and computational evidence in schizophrenia","volume":"88","author":"Limongi","year":"2020","journal-title":"Biol Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx198","article-title":"Should I stay or should I go? FMRI study of response inhibition in early illness schizophrenia and risk for psychosis","volume":"45","author":"Fryer","year":"2019","journal-title":"Schizophr Bull"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114533600","article-title":"Double-blind, randomized sham controlled study of deep-TMS add-on treatment for negative symptoms and cognitive deficits in schizophrenia","volume":"28","author":"Rabany","year":"2014","journal-title":"J Psychopharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116756","article-title":"Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial","volume":"353","author":"Xue","year":"2025","journal-title":"Psychiatry Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41398-023-02616-x","article-title":"Metformin improves cognitive impairment in patients with schizophrenia: Associated with enhanced functional connectivity of dorsolateral prefrontal cortex","volume":"13","author":"Shao","year":"2023","journal-title":"Transl Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamapsychiatry.2014.1734","article-title":"Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia","volume":"72","author":"Sarpal","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","article-title":"CONSORT 2025 statement: Updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e081660","DOI":"10.1136\/bmj-2024-081660","article-title":"SPIRIT 2025 explanation and elaboration: Updated guideline for protocols of randomised trials","volume":"389","author":"Hr\u00f3bjartsson","year":"2025","journal-title":"BMJ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2026.117216","article-title":"Effects of fronto-occipital transcranial alternating current stimulation for treating schizophrenia with prominent negative symptoms: A double-blind, randomized, sham-controlled trial","volume":"362","author":"Wu","year":"2026","journal-title":"Psychiatry Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2003.11.008","article-title":"The heterogeneity of schizophrenia in disease states","volume":"71","author":"Mohr","year":"2004","journal-title":"Schizophr Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2014.04.012","article-title":"Frontal theta as a mechanism for cognitive control","volume":"18","author":"Cavanagh","year":"2014","journal-title":"Trends Cognit Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/psyp.70269","article-title":"The distinct roles of the dorsolateral prefrontal cortex and dorsal anterior cingulate cortex in cognitive control: Evidence from transcranial temporal interference stimulation","volume":"63","author":"Chen","year":"2026","journal-title":"Psychophysiology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.03.024","article-title":"Norms and standardization of the brief assessment of cognition in schizophrenia (BACS)","volume":"102","author":"Keefe","year":"2008","journal-title":"Schizophr Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acw100","article-title":"The Chinese version of the brief assessment of cognition in schizophrenia: Data of a large-scale mandarin-speaking population","volume":"32","author":"Wang","year":"2017","journal-title":"Arch Clin Neuropsychol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1192\/S0007125000291496","article-title":"The scale for the assessment of negative symptoms (SANS): Conceptual and theoretical foundations","volume":"155","author":"Andreasen","year":"1989","journal-title":"Br J Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(91)90040-V","article-title":"Reliability and validity of the apathy evaluation scale","volume":"38","author":"Marin","year":"1991","journal-title":"Psychiatry Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.14096\/j.cnki.cn34-1069\/n\/1004-4329(2019)01-088-05","article-title":"Reliability and validity of the revised Chinese version of the self-report Apathy Evaluation Scale","volume":"36","author":"Shi","year":"2019","journal-title":"J Fuyang Normal Univ Nat Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jrp.2005.11.001","article-title":"Anticipatory and consummatory components of the experience of pleasure: A scale development study","volume":"40","author":"Gard","year":"2006","journal-title":"J Res Pers"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-6729.2009.11.008","article-title":"Reliability and validity of the Chinese version of the Personal and Social Performance Scale in patients with schizophrenia","volume":"23","author":"Si","year":"2009","journal-title":"Chin Ment Health J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-37","article-title":"Quality of life of Chinese urban community residents: A psychometric study of the mainland chinese version of the WHOQOL-BREF","volume":"12","author":"Xia","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-4346-x","article-title":"Psychometric evaluation of the Chinese version of the pittsburgh sleep quality index (CPSQI) in primary insomnia and control subjects","volume":"14","author":"Tsai","year":"2005","journal-title":"Qual Life Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.05.021","article-title":"Reliability and validity of the Chinese version of the patient health questionnaire (PHQ-9) in the general population","volume":"36","author":"Wang","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-0829.2010.04.002","article-title":"Reliability and validity of the Generalized Anxiety Disorder Scale in general hospital outpatients","volume":"22","author":"He","year":"2010","journal-title":"Shanghai Arch Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/11.9.825","article-title":"Anterior cingulate cortex and response conflict: Effects of frequency, inhibition and errors","volume":"11","author":"Braver","year":"2001","journal-title":"Cereb Cortex"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1089910","article-title":"Anterior cingulate conflict monitoring and adjustments in control","volume":"303","author":"Kerns","year":"2004","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0005-7916(00)00012-4","article-title":"Psychometric properties of the credibility\/expectancy questionnaire","volume":"31","author":"Devilly","year":"2000","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2018.02.009","article-title":"Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: Meta-analysis of controlled trials","volume":"89","author":"Aleman","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"20357","DOI":"10.1038\/s41598-021-99749-0","article-title":"Interindividual variability of electric fields during transcranial temporal interference stimulation (tTIS)","volume":"11","author":"von Conta","year":"2021","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14497","article-title":"The time course of ineffective sham\u2010blinding during low\u2010intensity (1 mA) transcranial direct current stimulation","volume":"50","author":"Greinacher","year":"2019","journal-title":"Eur J Neurosci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2174\/0929867311320030014","article-title":"Antipsychotic drug effects in schizophrenia: A review of longitudinal fMRI investigations and neural interpretations","volume":"20","author":"Abbott","year":"2013","journal-title":"Curr Med Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-08112","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1915709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:34:15Z","timestamp":1788240855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1915709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":49,"alternative-id":["10.3389\/fpsyt.2026.1915709"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1915709","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1915709"}}